000 | 01819 a2200505 4500 | ||
---|---|---|---|
005 | 20250516060156.0 | ||
264 | 0 | _c20120803 | |
008 | 201208s 0 0 eng d | ||
022 | _a1461-7285 | ||
024 | 7 |
_a10.1177/0269881111415737 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWolff, Kim | |
245 | 0 | 0 |
_aPharmacogenetic studies of change in cortisol on ecstasy (MDMA) consumption. _h[electronic resource] |
260 |
_bJournal of psychopharmacology (Oxford, England) _cMar 2012 |
||
300 |
_a419-28 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAmino Acid Substitution |
650 | 0 | 4 |
_aBiomarkers _xblood |
650 | 0 | 4 | _aBiotransformation |
650 | 0 | 4 |
_aCatechol O-Methyltransferase _xgenetics |
650 | 0 | 4 | _aCohort Studies |
650 | 0 | 4 |
_aCytochrome P-450 CYP2D6 _xgenetics |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGenetic Association Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydrocortisone _xblood |
650 | 0 | 4 |
_aHypothalamo-Hypophyseal System _xdrug effects |
650 | 0 | 4 |
_aIllicit Drugs _xpharmacokinetics |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aN-Methyl-3,4-methylenedioxyamphetamine _xpharmacokinetics |
650 | 0 | 4 |
_aNeurotoxicity Syndromes _xblood |
650 | 0 | 4 |
_aPituitary-Adrenal System _xdrug effects |
650 | 0 | 4 | _aPolymorphism, Genetic |
650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
650 | 0 | 4 |
_aSerotonin Plasma Membrane Transport Proteins _xgenetics |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aTsapakis, Evangelia M | |
700 | 1 | _aPariante, Carmine M | |
700 | 1 | _aKerwin, Robert W | |
700 | 1 | _aForsling, Mary L | |
700 | 1 | _aAitchison, Katherine J | |
773 | 0 |
_tJournal of psychopharmacology (Oxford, England) _gvol. 26 _gno. 3 _gp. 419-28 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/0269881111415737 _zAvailable from publisher's website |
999 |
_c21205297 _d21205297 |